EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Association of metabolic syndrome and chronic kidney disease

Florian G Scurt iD, Maximilian J Ganz, Carolin Herzog, Katrin Bose, Peter R Mertens, Christos Chatzikyrkou

Obesity Reviews · 2024-01 · 25 (1)

DOI: 10.1111/obr.13649 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Obesity Reviews, online erschienen am 02.10.2023. Verfasst von Florian G Scurt und 5 weiteren Autor:innen. Beteiligte Einrichtung: University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology, Medical Faculty, Otto-von Guericke University Magdeburg, Magdeburg,…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Insulin Resistance, Renal Insufficiency, Chronic, Diabetes Mellitus. Die Arbeit wurde bisher 156-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of kidney disease is increasing rapidly worldwide, reflecting rising rates of obesity, diabetes, and associated metabolic syndrome (MetS). Chronic kidney disease and related comorbidities such as obesity, diabetes, and hypertension place a significant financial burden on healthcare systems. Despite the widespread use of RAAS inhibitors, intensive blood pressure and glycemic control, and newer therapeutic options consisting of sodium/glucose cotransporter‐2 (SGLT‐2) inhibitors or glucagon‐like peptide‐1 (GLP‐1) receptor agonists, a significant risk of progression to end‐stage renal disease remains in the high‐risk obese and diabetic population. The MetS is a cluster of cardiovascular risk factors that adversely affect the development and progression of chronic kidney failure. According to the criteria of the World Health Organization, it is defined by visceral adiposity, impaired glucose tolerance or insulin resistance, atherogenic dyslipidemia, raised blood pressure, and microalbuminuria with a albumin‐to‐creatinine ratio ≥30 mg/g. At molecular level MetS is marked by a proinflammatory state and increased oxidative stress leading to various pathophysiological changes causing endothelial dysfunction and a hypercoagulable state. Because the kidney is a highly vascularized organ, it is especially susceptible for those microvascular changes. Therefore, the MetS and its individual components are associated with the premature development, acceleration, and progression of chronic kidney disease. Therefore, it is becoming increasingly important to elucidate the underlying mechanisms of MetS‐associated chronic kidney disease in order to develop new strategies for preventing and slowing the progression of renal disease. In this review, we will elucidate (i) the renal structural, hemodynamic, and metabolic changes that occur in obesity and obesity‐related kidney injury; (ii) the clinicopathological characteristics of obesity‐related kidney injury, primarily focusing on obesity‐associated glomerulopathy; (iii) the potential additional factors or predisposing factors that may turn patients more susceptible to renal structural or functional compensatory failure and subsequent injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeInsulin ResistanceRenal Insufficiency, ChronicDiabetes MellitusHumansObesity

Stichwörter der Autor:innen

chronic inflammationchronic kidney diseasesdiabeteshypertensionmetabolic syndromeobesity

Autor:innen und Institutionen

  • University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology, Medical Faculty, Otto-von Guericke University Magdeburg, Magdeburg, Germany.
  • Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Magdeburg, Magdeburg, Germany.
  • Department of Nephrology, Hannover Medical School, Hanover, Germany.

ORCID-Profile: Florian G Scurt

Zitieren

APA

Scurt, F. G., Ganz, M. J., Herzog, C., Bose, K., Mertens, P. R., & Chatzikyrkou, C. (2024). Association of metabolic syndrome and chronic kidney disease. Obesity Reviews, 25(1). https://doi.org/10.1111/obr.13649

Vancouver

Scurt FG, Ganz MJ, Herzog C, Bose K, Mertens PR, Chatzikyrkou C. Association of metabolic syndrome and chronic kidney disease. Obesity Reviews. 2024;25(1). doi:10.1111/obr.13649

BibTeX
@article{Scurt2024,
  author = {Scurt, Florian G and Ganz, Maximilian J and Herzog, Carolin and Bose, Katrin and Mertens, Peter R and Chatzikyrkou, Christos},
  title = {Association of metabolic syndrome and chronic kidney disease},
  journal = {Obesity Reviews},
  year = {2024},
  volume = {25},
  number = {1},
  doi = {10.1111/obr.13649}
}
Kostenlos starten →